Drugs & Therapy Perspectives

, Volume 5, Issue 3, pp 11–12 | Cite as

Life-long drug therapy required for Wilson’s disease

New Drugs and Therapeutics
  • 4 Downloads

Keywords

Penicillamine Wilson Disease Copper Accumulation Trientine Iron Zinc 

References

  1. 1.
    Hefter H. Wilson’s Disease: review of pathophysiology, clinical features and drug treatment. CNS Drugs 1994; 2: 26–39CrossRefGoogle Scholar
  2. 2.
    Houwen RHJ, van Hattum J, Hoogenraad TU. Wilson disease. Neth J Med 1993; 43: 26–37PubMedGoogle Scholar
  3. 3.
    Scheinberg H. Wilson’s Disease. In: Wilson JD, et al, (Eds.) Harrison’s principles of internal medicine, 12th ed. New York, McGraw-Hill, 1991; pp. 1843–5Google Scholar
  4. 4.
    Stremmel W, Meyerrose K-W, Niederau C, et al. Wilson disease: clinical presentation, treatment, and survival. Ann Intern Med 1991; 115: 720–6PubMedGoogle Scholar
  5. 5.
    Physicians GenRx. Data Pharmaceutica Inc. New York 1994; pp. 1726–9 & 2185–7Google Scholar
  6. 6.
    American Hospital Formulary Service Drug Information. American Society of Hospital Pharmacists, Bethesda, 1994; pp. 1974–7Google Scholar
  7. 7.
    British National Formulary. 1993; 27: 361Google Scholar
  8. 8.
    Walshe JM, Yealland M. Chelation treatment of Wilson’s disease. Q J Med 1993; 86: 197–204PubMedGoogle Scholar

Copyright information

© Adis International Limited 1995

Personalised recommendations